The Circular RNA circSKA3 Facilitates the Malignant Biological Behaviors of Medulloblastoma via miR-520 h/CDK6 Pathway
- PMID: 35352283
- DOI: 10.1007/s12033-022-00466-4
The Circular RNA circSKA3 Facilitates the Malignant Biological Behaviors of Medulloblastoma via miR-520 h/CDK6 Pathway
Abstract
Circular RNAs (circRNAs) are reported to participate in the development of diverse human malignancies. This work investigated the mechanism of circSKA3 in modulating medulloblastoma progression. A total of 15 cases of medulloblastoma were collected in this work. Daoy cells were used to construct cell models. The expression level of circSKA3, microRNA-520 h (miR-520 h), and cyclin-dependent kinase 6 (CDK6) mRNA in tissues or cells was examined by quantitative real-time polymerase chain reaction (qRT-PCR). Western blot was employed to detect CDK6 protein expression. CCK-8 experiment, Transwell assay, and flow cytometry were applied to detect the regulatory effects of circSKA3 on cell proliferation, migration, invasion, and cell cycle. Dual-luciferase reporter gene experiment was executed to determine the relationship between circSKA3 and miR-520 h, and between miR-520 h and CDK6. circSKA3 was remarkably up-modulated in medulloblastoma tissues. CircSKA3 depletion markedly suppressed Daoy cell viability, migration, invasion, and cell cycle progression. CircSKA3 overexpression induced the opposite effects. circSKA3 could decoyed miR-520 h, which targeted the 3' UTR of CDK6. circSKA3 expression in medulloblastoma tissues was negatively correlated with miR-520 h expression and positively correlated with CDK6 expression. "Rescue" experiments revealed that miR-520 h down-modulation or CDK6 overexpression remarkably counteracted the inhibitory effect of circSKA3 knockdown on Daoy cells. circSKA3 facilitates medulloblastoma progression through miR-520 h/CDK6.
Keywords: CDK6; Medulloblastoma; circSKA3; miR-520 h.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Udaka, Y. T., & Packer, R. J. (2018). Pediatric brain tumors. Neurologic Clinics, 36(3), 533–556. - DOI
-
- Gupta, A., & Dwivedi, T. (2017). A simplified overview of world health organization classification update of central nervous system tumors 2016. J Neurosci Rural Pract, 8(4), 629–641. - DOI
-
- Gupta, T., Jalali, R., Goswami, S., Nair, V., Moiyadi, A., Epari, S., & Sarin, R. (2012). Early clinical outcomes demonstrate preserved cognitive function in children with average-risk medulloblastoma when treated with hyperfractionated radiation therapy. Int J Radiat Oncol Biol Phys, 83(5), 1534–1540. - DOI
-
- Gajjar, A. J., & Robinson, G. W. (2014). Medulloblastoma-translating discoveries from the bench to the bedside. Nat Rev Clin Oncol, 11(12), 714–722. - DOI
-
- Ashwal-Fluss, R., Meyer, M., Pamudurti, N. R., Ivanov, A., Bartok, O., Hanan, M., Evantal, N., Memczak, S., Rajewsky, N., & Kadener, S. (2014). circRNA biogenesis competes with pre-mRNA splicing. Mol Cell, 56(1), 55–66. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
